NCT06521567 2025-11-12A Study of Cobolimab Plus Dostarlimab in Pediatric and Young Adult Participants With CancerGlaxoSmithKlinePhase 1/2 Active not recruiting83 enrolled
NCT05974410 2025-10-02Expanded Access to Immunomodulatory AVM0703 for Solid Tumor and Blood Cancer PatientsAVM Biotechnology IncAvailable
NCT06363201 2024-04-12Effect and Safety of Ocoxin Oral Solution on the Quality of Life of Paediatric Patients With Advanced Stage Solid TumoursCatalysis SLPhase NA Not yet recruiting40 enrolled
NCT00002663 2023-02-13Biological Therapy in Treating Patients at High-Risk or With Lymphoma, Lymphoproliferative Disease, or MalignanciesAtara BiotherapeuticsPhase 1/2 Completed58 enrolled 18 charts
NCT02223052 2020-05-12Bioequivalence & Food Effect Study in Patients With Solid Tumor or Hematologic MalignanciesCelgenePhase 1 Completed89 enrolled
NCT01748721 2016-01-08MORAb-004 in Treating Young Patients With Recurrent or Refractory Solid Tumors or LymphomaMorphotekPhase 1 Completed27 enrolled
NCT00413075 2015-07-08Study of Oral PXD101 in Patients With Advanced Solid Tumors or LymphomaValerio TherapeuticsPhase 1 Completed121 enrolled
NCT00538850 2014-03-05Fentanyl Sublingual Spray in Treating Patients With Breakthrough Cancer PainINSYS Therapeutics IncPhase 3 Completed130 enrolled 9 charts
NCT00006368 2013-05-01Yttrium Y 90 SMT 487 in Treating Patients With Refractory or Recurrent CancerNovartisPhase 1 Completed60 enrolled
NCT00051597 2011-10-12A Safety/Efficacy Study of SGN-30 (Antibody) in Patients With Refractory or Recurrent CD30+ Hematologic MalignanciesSeagen Inc.Phase 1/2 Completed70 enrolled